About the Authors
- Pierre Druilhe
-
*To whom correspondence should be addressed. E-mail: druilhe@pasteur.fr
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
- François Spertini
-
Affiliation Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- Daw Soesoe
-
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
- Giampietro Corradin
-
Affiliation Institute of Biochemistry, University of Lausanne, Epalinges, Switzerland
- Pedro Mejia
-
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
- Subhash Singh
-
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
- Regine Audran
-
Affiliation Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
- Ahmed Bouzidi
-
Affiliation Sedac Therapeutics, Lille, France
- Claude Oeuvray
-
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
- Christian Roussilhon
-
Affiliation Biomedical Parasitology Unit, Pasteur Institute, Paris, France
Competing Interests
PD, DS, PM, SS, CO, and CR are affiliated with the Pasteur Institute, which holds a patent on merozoite surface protein 3.
Author Contributions
PD designed the study. DS, GC, PM, SS, and RA performed the biological experiments. PD, SS, RA, and CR analyzed the data. FS organized the clinical trial. AB and CO produced the vaccine. PD wrote the paper.